MedPath
NMPA Approval

Aclidinium Bromide Powder for Inhalation

国药准字HJ20240081

August 5, 2024

Drug Information

阿地溴铵吸入粉雾剂

吸入粉雾剂

每个吸入器60吸,每吸含阿地溴铵400μg,递送剂量为阿地溴铵375µg

化学药品

August 5, 2024

August 4, 2029

Company Information

Applicant Company

Gustav Mahlerplein 2, Amsterdam, NL-1082 MA, the Netherlands

Manufacturing Company

Ctra. de Martorell 41-61, Sant Andreu de la Barca (Barcelona), E-08740, Spain

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

阿地溴铵吸入粉雾剂 - NMPA 批准文号 | MedPath